PunchUK pardons women convicted of abortion offencesThe Jerusalem PostIDF blocks Area A road to new Jewish outpost near Jericho, confiscates residents' army weaponsInquirer3 top fugitives nabbed in Caraga police opsDaily MaverickHISTORY MAKERS: Wales’ shock victory over All Blacks gives Springboks Nations Championship lifeline한겨레서산·충주·예천 주민들 “광주 군 공항 이전 군용기 잠정 배치 반대”CNN Türkİslam Memiş kritik seviyeyi açıkladı: Altın bu rakamın altına inerse düşüş sürebilirZDF heuteAktuelle Pressemitteilungen des ZDFالنهارالكنيست يعيّن عربيين في منصب نائب رئيس الكنيست للمرّة الأولى!Wirtualna PolskaABW zatrzymała nastolatków. Szykowali zamachy w PolsceCBS NewsIran rules out inspections of damaged nuclear sites until war endsFotogramasGary Oldman, actor: "Me he dedicado a emborracharme hasta caer inconsciente en mi habitación del hotel estando en alguno de los lugares más bellos del planeta"GIGAZINEChatGPTのチャット内でクレカ決済できる「ChatGPT Wallet」が登場
The Daily Newsstand · Free, Always
Monday, November 16, 2026

Experimental chewing gum slashes cancer-causing HPV by 93%

Translate

An experimental chewing gum reduced levels of HPV, a major cause of multiple cancers, by more than 90 percent. 

Human papillomavirus (HPV) is perhaps the world's most pervasive sexually transmitted infection, affecting 85 percent of people at some point in their lifetime.

While the infection largely clears on its own, it can also lurk in the body for decades, quietly altering cell DNA and contributing to a host of cancers, namely cervical, head and neck and anal cancer.

Though vaccines against HPV have become commonplace in the last 20 years, millions of Americans have not received the shots, leaving them potentially vulnerable to HPV.

Now, researchers at the University of Pennsylvania have tested an experimental chewing gum with plant-based compounds aimed at reducing HPV, as well as bacteria associated with cancer.

In their study, the team collected saliva and oral rinse samples from patients diagnosed with head and neck squamous cell carcinoma, a group of cancers affecting the mouth, throat and tonsils. 

Among cancer patients with detectable levels of HPV, compounds in the gum reduced levels by 80 percent in oral rinse samples and 93 percent in saliva samples. 

It also slashed levels of two cancer-associated bacteria by more than 99 percent in just one treatment.  

Researchers at the University of Pennsylvania are developing a chewing gum that could reduce levels of HPV, which causes a large percentage of oral cancers

Additionally, the gum still was able to spare some healthy bacteria living in the mouth that have been shown to protect against harmful pathogens.

The researchers now plan to move the technology into human clinical trials in hopes of introducing a low-cost, accessible treatment for head and neck cancers.

'Lip and oral cavity cancer was the seventh leading cancer type in cancer incidence and mortality rate worldwide in adolescents, young adults, and middle-aged adults in 2022,' Dr Henry Daniell, lead study author from University of Pennsylvania's School of Dental Medicine, said.

'Our findings support the value of advancing these therapies to clinical trials as adjuvants with current treatments or as prophylaxis to prevent infection and transmission.'

Prophylaxis means measures taken to prevent disease or infection before it occurs. 

HPV is responsible for about one in four head and neck cancers overall and 60 to 70 percent of all oropharyngeal cancers, which affect the back of the throat, tonsils and the base of the tongue. 

It's also responsible for nearly all cervical cancers, as well as large concentrations of anal, vaginal, vulvar and penile cancers. 

The US sees about 72,000 new head and neck cancer diagnoses each year, along with 17,000 deaths, according to the National Cancer Institute. 

The University of Pennsylvania study, published earlier this year in the journal Scientific Reports, looked at two formulations of chewing gum, both based on bean powder extracted from lablab beans. 

One gum, containing the plant compound Flt3 receptor-interacting lectin, targeted HPV particles while the other, containing the peptide protegrin-1, targeted the bacteria Porphyrpmonas gingivalis and Fusobacterium nucleatum, which have been associated with oral cancer. 

Samples were collected from 44 head and neck cancer patients. Researchers used those samples to test extracts taken from the gum. 

The team found up to a 90 percent reduction in HPV-16, the leading high-risk HPV strain responsible for most cervical and oral cancers. It also reduced levels of the tested bacteria by more than 99 percent. 

And unlike more aggressive treatments like radiation, the compounds in the gum still spared beneficial bacteria without encouraging the growth of other pathogens. 

Importantly, the results came from testing the extracts on patient samples rather than giving patients the gum itself, so the team notes additional research is needed.  

View the original on Daily Mail →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.